ArticleDiabetes, obesity & metabolism2025

The effect of sodium-glucose cotransporter 2 inhibitors on HbA1c variability and cardiovascular and renal adverse outcome in patients with T2DM.

Ran Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.